{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:39:18Z","timestamp":1789785558995,"version":"4.0.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL157489"],"award-info":[{"award-number":["R01HL157489"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["P01-HL060678"],"award-info":[{"award-number":["P01-HL060678"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01-HL154538"],"award-info":[{"award-number":["R01-HL154538"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01-HL152515"],"award-info":[{"award-number":["R01-HL152515"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["P01-HL151327"],"award-info":[{"award-number":["P01-HL151327"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["P01-HL060678"],"award-info":[{"award-number":["P01-HL060678"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01-HL154538"],"award-info":[{"award-number":["R01-HL154538"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32-HL007829"],"award-info":[{"award-number":["T32-HL007829"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["P01-HL151327"],"award-info":[{"award-number":["P01-HL151327"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01-HL152515"],"award-info":[{"award-number":["R01-HL152515"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R43-AI162329"],"award-info":[{"award-number":["R43-AI162329"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R43-AI162329"],"award-info":[{"award-number":["R43-AI162329"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"name":"C3.ai Digital Transformation Institute Research Award provided by C3.ai Inc. and Microsoft Corporation"},{"name":"University of Illinois College of Medicine intramural funds"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Vaccine hesitancy and emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) escaping vaccine-induced immune responses highlight the urgency for new COVID-19 therapeutics. Engineered angiotensin-converting enzyme 2 (ACE2) proteins with augmented binding affinities for SARS-CoV-2 spike (S) protein may prove to be especially efficacious against multiple variants. Using molecular dynamics simulations and functional assays, we show that three amino acid substitutions in an engineered soluble ACE2 protein markedly augmented the affinity for the S protein of the SARS-CoV-2 WA-1\/2020 isolate and multiple VOCs: B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma) and B.1.617.2 (Delta). In humanized K18-hACE2 mice infected with the SARS-CoV-2 WA-1\/2020 or P.1 variant, prophylactic and therapeutic injections of soluble ACE2\n                    <jats:sub>2<\/jats:sub>\n                    .v2.4-IgG1 prevented lung vascular injury and edema formation, essential features of CoV-2-induced SARS, and above all improved survival. These studies demonstrate broad efficacy in vivo of an engineered ACE2 decoy against SARS-CoV-2 variants in mice and point to its therapeutic potential.\n                  <\/jats:p>","DOI":"10.1038\/s41589-021-00965-6","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T06:02:56Z","timestamp":1642572176000},"page":"342-351","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants"],"prefix":"10.1038","volume":"18","author":[{"given":"Lianghui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumajit","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqin","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9826-1983","authenticated-orcid":false,"given":"Matthew","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui K.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith L.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Lindeblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6322-1260","authenticated-orcid":false,"given":"Laura M.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony F.","family":"Gugliuzza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diwakar","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0028-490X","authenticated-orcid":false,"given":"Erik","family":"Procko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2787-9292","authenticated-orcid":false,"given":"Jalees","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8205-7128","authenticated-orcid":false,"given":"Asrar B.","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,19]]},"reference":[{"key":"965_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403\u2013416 (2021).","journal-title":"N. Engl. J. Med."},{"key":"965_CR2","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","volume":"384","author":"N Dagan","year":"2021","unstructured":"Dagan, N. et al. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N. Engl. J. Med. 384, 1412\u20131423 (2021).","journal-title":"N. Engl. J. Med."},{"key":"965_CR3","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1056\/NEJMms2101220","volume":"384","author":"L Rosenbaum","year":"2021","unstructured":"Rosenbaum, L. Escaping catch-22\u2014Overcoming Covid vaccine hesitancy. N. Engl. J. Med. 384, 1367\u20131371 (2021).","journal-title":"N. Engl. J. Med."},{"key":"965_CR4","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1016\/j.cell.2021.04.006","volume":"184","author":"WF Garcia-Beltran","year":"2021","unstructured":"Garcia-Beltran, W. F. et al. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell 184, 2523 (2021).","journal-title":"Cell"},{"key":"965_CR5","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1016\/j.cell.2021.03.036","volume":"184","author":"M Hoffmann","year":"2021","unstructured":"Hoffmann, M. et al. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies. Cell 184, 2384\u20132393.e12 (2021).","journal-title":"Cell"},{"key":"965_CR6","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.cell.2020.11.032","volume":"183","author":"AC Walls","year":"2020","unstructured":"Walls, A. C. et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 183, 1735 (2020).","journal-title":"Cell"},{"key":"965_CR7","doi-asserted-by":"publisher","first-page":"11727","DOI":"10.1073\/pnas.2003138117","volume":"117","author":"J Shang","year":"2020","unstructured":"Shang, J. et al. Cell entry mechanisms of SARS-CoV-2. Proc. Natl Acad. Sci. USA 117, 11727\u201311734 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"965_CR8","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1126\/science.abc7424","volume":"369","author":"AZ Wec","year":"2020","unstructured":"Wec, A. Z. et al. Broad neutralization of SARS-related viruses by human monoclonal antibodies. Science 369, 731\u2013736 (2020).","journal-title":"Science"},{"key":"965_CR9","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1126\/science.abc2241","volume":"368","author":"Y Wu","year":"2020","unstructured":"Wu, Y. et al. A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Science 368, 1274\u20131278 (2020).","journal-title":"Science"},{"key":"965_CR10","doi-asserted-by":"publisher","first-page":"e20201993","DOI":"10.1084\/jem.20201993","volume":"218","author":"A Sch\u00e4fer","year":"2021","unstructured":"Sch\u00e4fer, A. Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo. J. Exp. Med. 218, e20201993 (2021).","journal-title":"J. Exp. Med."},{"key":"965_CR11","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.chom.2021.04.007","volume":"29","author":"P Wang","year":"2021","unstructured":"Wang, P. et al. Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell Host Microbe 29, 747\u2013751.e4 (2021).","journal-title":"Cell Host Microbe"},{"key":"965_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","volume":"593","author":"P Wang","year":"2021","unstructured":"Wang, P. et al. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature 593, 130\u2013135 (2021).","journal-title":"Nature"},{"key":"965_CR13","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","volume":"181","author":"V Monteil","year":"2020","unstructured":"Monteil, V. et al. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell 181, 905\u2013913.e7 (2020).","journal-title":"Cell"},{"key":"965_CR14","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1126\/science.abc0870","volume":"369","author":"KK Chan","year":"2020","unstructured":"Chan, K. K. et al. Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2. Science 369, 1261\u20131265 (2020).","journal-title":"Science"},{"key":"965_CR15","doi-asserted-by":"publisher","unstructured":"Iwanaga, N. et al. Novel ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV2. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2020.06.15.152157 (2020).","DOI":"10.1101\/2020.06.15.152157"},{"key":"965_CR16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41586-020-2787-6","volume":"586","author":"C Mu\u00f1oz-Fontela","year":"2020","unstructured":"Mu\u00f1oz-Fontela, C. et al. Animal models for COVID-19. Nature 586, 509\u2013515 (2020).","journal-title":"Nature"},{"key":"965_CR17","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/s41590-020-0778-2","volume":"21","author":"ES Winkler","year":"2020","unstructured":"Winkler, E. S. et al. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat. Immunol. 21, 1327\u20131335 (2020).","journal-title":"Nat. Immunol."},{"key":"965_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10134-y","volume":"10","author":"M Liu","year":"2019","unstructured":"Liu, M. et al. Sox17 is required for endothelial regeneration following inflammation-induced vascular injury. Nat. Commun. 10, 2126 (2019).","journal-title":"Nat. Commun."},{"key":"965_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","volume":"5","author":"MA Matthay","year":"2019","unstructured":"Matthay, M. A. et al. Acute respiratory distress syndrome. Nat. Rev. Dis. Primers 5, 18 (2019).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"965_CR20","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.1021\/acs.jpcb.1c00869","volume":"125","author":"AH Williams","year":"2021","unstructured":"Williams, A. H. & Zhan, C.-G. Fast prediction of binding affinities of the SARS-CoV-2 spike protein mutant N501Y (UK variant) with ACE2 and miniprotein drug candidates. J. Phys. Chem. B 125, 4330\u20134336 (2021).","journal-title":"J. Phys. Chem. B"},{"key":"965_CR21","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","volume":"181","author":"CGK Ziegler","year":"2020","unstructured":"Ziegler, C. G. K. et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell 181, 1016\u20131035.e19 (2020).","journal-title":"Cell"},{"key":"965_CR22","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s40262-013-0072-7","volume":"52","author":"M Haschke","year":"2013","unstructured":"Haschke, M. et al. Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects. Clin. Pharmacokinet. 52, 783\u2013792 (2013).","journal-title":"Clin. Pharmacokinet."},{"key":"965_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280.e8 (2020).","journal-title":"Cell"},{"key":"965_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41586-021-03720-y","volume":"596","author":"RE Chen","year":"2021","unstructured":"Chen, R. E. et al. In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains. Nature 596, 103\u2013108 (2021).","journal-title":"Nature"},{"key":"965_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25153-x","volume":"12","author":"S Zhao","year":"2021","unstructured":"Zhao, S. et al. Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylactics. Nat. Commun. 12, 4887 (2021).","journal-title":"Nat. Commun."},{"key":"965_CR26","doi-asserted-by":"publisher","unstructured":"Peter, A. S. et al. A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model. Eur. J. Immunol. https:\/\/doi.org\/10.1002\/eji.202149374 (2021).","DOI":"10.1002\/eji.202149374"},{"key":"965_CR27","doi-asserted-by":"publisher","first-page":"eabf1738","DOI":"10.1126\/sciadv.abf1738","volume":"7","author":"KK Chan","year":"2020","unstructured":"Chan, K. K., Tan, T. J. C., Narayanan, K. K. & Procko, E. An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants. Sci. Adv. 7, eabf1738 (2020).","journal-title":"Sci. Adv."},{"key":"965_CR28","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1126\/science.abd0827","volume":"369","author":"J Hansen","year":"2020","unstructured":"Hansen, J. et al. Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. Science 369, 1010\u20131014 (2020).","journal-title":"Science"},{"key":"965_CR29","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1056\/NEJMoa2035002","volume":"384","author":"DM Weinreich","year":"2021","unstructured":"Weinreich, D. M. et al. REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19. N. Engl. J. Med. 384, 238\u2013251 (2021).","journal-title":"N. Engl. J. Med."},{"key":"965_CR30","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S0140-6736(21)00183-5","volume":"397","author":"EC Sabino","year":"2021","unstructured":"Sabino, E. C. et al. Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence. Lancet 397, 452\u2013455 (2021).","journal-title":"Lancet"},{"key":"965_CR31","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1164\/rccm.202001-0179LE","volume":"202","author":"Y Zhao","year":"2020","unstructured":"Zhao, Y. et al. Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2. Am. J. Respir. Crit. Care Med. 202, 756\u2013759 (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"965_CR32","doi-asserted-by":"publisher","first-page":"eabe8146","DOI":"10.1126\/scitranslmed.abe8146","volume":"13","author":"E Speranza","year":"2021","unstructured":"Speranza, E. et al. Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys. Sci. Transl. Med. 13, eabe8146 (2021).","journal-title":"Sci. Transl. Med."},{"key":"965_CR33","first-page":"e51413","volume":"9","author":"A Jambusaria","year":"2020","unstructured":"Jambusaria, A. et al. Endothelial heterogeneity across distinct vascular beds during homeostasis and inflammation. eLife 9, e51413 (2020).","journal-title":"ife"},{"key":"965_CR34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","volume":"184","author":"R Karki","year":"2021","unstructured":"Karki, R. et al. Synergism of TNF-\u03b1 and IFN-\u03b3 triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell 184, 149\u2013168.e17 (2021).","journal-title":"Cell"},{"key":"965_CR35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41586-021-03570-8","volume":"595","author":"TM Delorey","year":"2021","unstructured":"Delorey, T. M. et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature 595, 107\u2013113 (2021).","journal-title":"Nature"},{"key":"965_CR36","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41591-021-01294-w","volume":"27","author":"RE Chen","year":"2021","unstructured":"Chen, R. E. et al. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat. Med. 27, 717\u2013726 (2021).","journal-title":"Nat. Med."},{"key":"965_CR37","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.abh1139","volume":"373","author":"M Yuan","year":"2021","unstructured":"Yuan, M. et al. Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants. Science 373, 818\u2013823 (2021).","journal-title":"Science"},{"key":"965_CR38","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/science.abd2161","volume":"369","author":"DS Candido","year":"2020","unstructured":"Candido, D. S. et al. Evolution and epidemic spread of SARS-CoV-2 in Brazil. Science 369, 1255\u20131260 (2020).","journal-title":"Science"},{"key":"965_CR39","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1016\/j.cell.2021.06.002","volume":"184","author":"R Copin","year":"2021","unstructured":"Copin, R. et al. The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies. Cell 184, 3949\u20133961.e11 (2021).","journal-title":"Cell"},{"key":"965_CR40","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03712","volume":"436","author":"Y Imai","year":"2005","unstructured":"Imai, Y. et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436, 112\u2013116 (2005).","journal-title":"Nature"},{"key":"965_CR41","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.cell.2020.10.005","volume":"183","author":"M Aid","year":"2020","unstructured":"Aid, M. et al. Vascular disease and thrombosis in SARS-CoV-2-infected rhesus macaques. Cell 183, 1354\u20131366.e13 (2020).","journal-title":"Cell"},{"key":"965_CR42","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1038\/s41596-020-0394-5","volume":"15","author":"J Nie","year":"2020","unstructured":"Nie, J. et al. Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay. Nat. Protoc. 15, 3699\u20133715 (2020).","journal-title":"Nat. Protoc."},{"key":"965_CR43","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan, R. et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367, 1444\u20131448 (2020).","journal-title":"Science"},{"key":"965_CR44","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1002\/jcc.21224","volume":"30","author":"L Mart\u00ednez","year":"2009","unstructured":"Mart\u00ednez, L., Andrade, R., Birgin, E. G. & Martinez, J. M. PACKMOL: a package for building initial configurations for molecular dynamics simulations. J. Comput. Chem. 30, 2157\u20132164 (2009).","journal-title":"J. Comput. Chem."},{"key":"965_CR45","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier, J. A. et al. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 11, 3696\u20133713 (2015).","journal-title":"J. Chem. Theory Comput."},{"key":"965_CR46","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/jcc.20820","volume":"29","author":"KN Kirschner","year":"2008","unstructured":"Kirschner, K. N. et al. GLYCAM06: a generalizable biomolecular force field. Carbohydrates. J. Comput. Chem. 29, 622\u2013655 (2008).","journal-title":"J. Comput. Chem."},{"key":"965_CR47","first-page":"1857","volume":"9","author":"YP Pang","year":"2000","unstructured":"Pang, Y. P., Xu, K., Yazal, J. E. & Prendergas, F. G. Successful molecular dynamics simulation of the zinc-bound farnesyltransferase using the cationic dummy atom approach. Protein Sci. 9, 1857\u20131865 (2000).","journal-title":"Protein Sci."},{"key":"965_CR48","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","volume":"23","author":"J-P Ryckaert","year":"1977","unstructured":"Ryckaert, J.-P., Ciccotti, G. & Berendsen, H. J. C. Numerical-integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 23, 327\u2013341 (1977).","journal-title":"J. Comput. Phys."},{"key":"965_CR49","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1021\/ct900620b","volume":"6","author":"GR Bowman","year":"2010","unstructured":"Bowman, G. R., Ensign, D. L. & Pande, V. S. Enhanced modeling via network theory: adaptive sampling of Markov state models. J. Chem. Theory Comput. 6, 787\u2013794 (2010).","journal-title":"J. Chem. Theory Comput."},{"key":"965_CR50","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1126\/science.290.5498.1903","volume":"290","author":"M Shirts","year":"2000","unstructured":"Shirts, M. & Pande, V. S. COMPUTING: screen savers of the world unite! Science 290, 1903\u20131904 (2000).","journal-title":"Science"},{"key":"965_CR51","doi-asserted-by":"publisher","first-page":"e1005659","DOI":"10.1371\/journal.pcbi.1005659","volume":"13","author":"P Eastman","year":"2017","unstructured":"Eastman, P. et al. OpenMM 7: rapid development of high performance algorithms for molecular dynamics. PLoS Comput. Biol. 13, e1005659 (2017).","journal-title":"PLoS Comput. Biol."},{"key":"965_CR52","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1021\/acs.jctc.5b00743","volume":"11","author":"MK Scherer","year":"2015","unstructured":"Scherer, M. K. et al. PyEMMA 2: a software package for estimation, validation, and analysis of Markov models. J. Chem. Theory Comput. 11, 5525\u20135542 (2015).","journal-title":"J. Chem. Theory Comput."},{"key":"965_CR53","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.bpj.2015.08.015","volume":"109","author":"RT McGibbon","year":"2015","unstructured":"McGibbon, R. T. et al. MDTraj: a modern open library for the analysis of molecular dynamics trajectories. Biophys. J. 109, 1528\u20131532 (2015).","journal-title":"Biophys. J."},{"key":"965_CR54","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/ct400341p","volume":"9","author":"DR Roe","year":"2013","unstructured":"Roe, D. R. & Cheatham, T. E. 3rd PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J. Chem. Theory Comput. 9, 3084\u20133095 (2013).","journal-title":"J. Chem. Theory Comput."},{"key":"965_CR55","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 14, 33\u201338 (1996).","journal-title":"J. Mol. Graph."}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41589-021-00965-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-021-00965-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-021-00965-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T10:09:48Z","timestamp":1650276588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41589-021-00965-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,19]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["965"],"URL":"https:\/\/doi.org\/10.1038\/s41589-021-00965-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.12.21.473668","asserted-by":"object"}]},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,19]]},"assertion":[{"value":"22 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.Z., S.X., J.R., E.P. and A.B.M. are inventors on a patent filing by the University of Illinois covering the use of engineered polypeptides targeting coronaviruses. E.P. is a consultant and stockholder of Cyrus Biotechnology, which licenses the intellectual property.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}